The Status of Gene Therapy for Cystic Fibrosis

Seminars in Respiratory and Critical Care Medicine

Volumn 24, Issue 6, 2003, Pages 749-770

  Weiss, Daniel J ^a   Pilewski, Joseph M ^b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adeno associated virus; Adenovirus; Airway epithelium; Cystic fibrosis; Gene therapy

Indexed keywords

ADENOVIRUS VECTOR; CALCIUM PHOSPHATE; CARBOXYMETHYLCELLULOSE; DNA; EGTAZIC ACID; GLYCOCONJUGATE; LENTIVIRUS VECTOR; LIPOSOME; PERFLUORO COMPOUND; PLASMID DNA; POLYCATION; RETROVIRUS VECTOR; SURFACTANT; VIRUS VECTOR;

CELL ORGANELLE; CELL SURFACE; CLINICAL TRIAL; CYSTIC FIBROSIS; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; HUMAN; IMMUNE RESPONSE; INFLAMMATION; ION TRANSPORT; MEMBRANE TRANSPORT; PATHOGENESIS; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM; REVIEW; STEM CELL; SUBMUCOSA; VIRUS INFECTION; VIRUS RECOMBINANT;

EID: 0347812926     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815670     Document Type: Review

References (254)

1. Riordan JR, Rommens JM, Kerem BS, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073
2. Rommens JM, Iannuzzxi MC, Kerem BS, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-1065
3. Collins FS. Cystic fibrosis: molecular biology and therapeutic implications. Science 1992;256:774-779
4. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-1254
5. Mulligan RC. The basic science of gene therapy. Science 1993;260:926-932
6. Pilewski JM, Frizzell RA. Role of CFTR in airway disease. Physiol Rev 1999;79(suppl 1):S215-S255
7. Wine JJ. The genesis of cystic fibrosis lung disease. J Clin Invest 1999;103:309-312
8. Rich DP, Anderson MP, Gregory RJ, et al. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 1990;347:358-363
9. Sheppard DN, Welsh MJ. Structure and function of the CFTR chloride channel. Physiol Rev 1999;79:S23-S45
10. Schwiebert EM, Benos DJ, Egan ME, Stutts MJ, Guggino WB. CFTR is a conductance regulator as well as a chloride channel. Physiol Rev 1999;79:S145-S166
11. Kunzelmann K. Mechanisms of the inhibition of epithelial Na(+) channels by CFTR and purinergic stimulation. Kidney Int 2001;60:455-461
12. Boucher RC. Airway epithelial fluid transport. Am Rev Respir Dis 1994;150:271-281, 581-593
13. Cheng PW, Boat TF, Cranfill K, Yankaskas JR, Boucher RC. Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis. J Clin Invest 1989;84:68-72
14. Imundo L, Barasch J, Prince A, Al-Awqati Q. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc Natl Acad Sci USA 1995;92:3019-3023
15. Barasch J, Kiss B, Prince A, Saiman L, Gruenert D, AlAwqati Q. Acidification of intracellular organelles is defective in cystic fibrosis. Nature 1992;352:70-73
16. Poschet JF, Boucher JC, Tatterson L, Skidmore J, Van Dyke RW, Deretic V. Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung. Proc Natl Acad Sci USA 2001;98:13972-13977
17. Coakley RD, Boucher RC. Regulation and functional significance of airway surface liquid pH. JOP Journal of Pancreas 2001;2(suppl 4):S294-S300
18. Bradbury NA, Jilling T, Berta G, Sorscher EJ, Bridges RJ, Kirk KL. Regulation of plasma membrane recycling by CFTR. Science 1992;256:530-532
19. Bradbury NA. Intracellular CFTR: localization and function. Physiol Rev 1999;79:S175-S191
20. Lloyd Mills CM, Pereira MC, Dormer RL, McPherson MA. An antibody against a CFTR derived synthetic peptide inhibits beta-adrenergic stimulation of mucin secretion. Biochem Biophys Res Commun 1992;188:1146-1152
21. Gao L, Kim KJ, Yankaskas JR, Forman HJ. Abnormal glutathione transport in cystic fibrosis airway epithelia. Am J Physiol 1999;277:L113-L118
22. Matsui H, Grubb BR, Tarran R, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998;95:1005-1015
23. Trapnell BC, Chu CS, Paako PK, et al. Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc Natl Acad Sci USA 1991;88:6565-6569
24. Engelhardt JF, Zepeda M, Cohn JA, Yankaskas JR, Wilson JM. Expression of the cystic fibrosis gene in adult human lung. J Clin Invest 1994;93:737-749
25. Engelhardt JF, Yankaskas JR, Ernst SA, et al. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet 1992;2:240-248
26. Jacquot J, Puchelle E, Hinnrasky J, et al. Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands. Eur Respir J 1993;6:169-176
27. Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 2002;109:571-577
28. Drumm ML, Pope HA, Cliff WH, et al. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 1990;62:1227-1233
29. Rich DP, Anderson MP, Gregory RJ, et al. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 1990;347:358-363
30. Oceandy D, McMorran BJ, Smith SN, et al. Gene complementation of airway epithelium in the cystic fibrosis mouse is necessary and sufficient to correct the pathogen clearance and inflammatory abnormalities. Hum Mol Genet 2002;11:1059-1067
31. Johnson LG, Olsen JC, Sarkadi B, Moore KL, Swanstrom R, Boucher RC. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet 1992;2:21-25
32. Johnson LG, Boyles SE, Wilson J, Boucher RC, Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. J Clin Invest 1995;95:1377-1382
33. Ramalho AS, Beck S, Meyer M, Penque D, Cutting GR, Amaral MD. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am J Respir Cell Mol Biol 2002;27:619-627
34. Pickles RJ, McCarty D, Matsui H, Hart PJ, Randell SH, Boucher RC. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J Virol 1998;72:6014-6023
35. Walters RW, Grunst T, Bergelson JM, Finberg RW, Wlesh MJ, Zabner J. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J Biol Chem 1999;274:10219-10226
36. Wang G, Zabner J, Deering C, et al. Increasing epithelial junction permeability enhances gene transfer to mouse tracheal epithelium in vivo. Am J Respir Cell Mol Biol 2000;22:129-138
37. Chu Q, St. George JA, Lukason M, Cheng SH, Scheule RK, Eastman SJ. EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in vivo. Hum Gene Ther 2001;12:455-467
38. Pickles RJ, Fahrner JA, Petrella JM, Boucher RC, Bergelson JM. Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer. J Virol 2000;74:6050-6057
39. Pilewski JM, Laroche JD, Arcasoy SM, Albelda SM. Expression in integrin cell adhesion receptors during human airway epithelial repair in vivo. Am J Physiol 1997;273:L256-L263
40. Kitson C, Angel B, Judd D, et al. The extra-and intercellular barriers to lipid and adenovirus-mediated pulmonary gene transfer to native sheep airway epithelium. Gene Ther 1998;6:534-546
41. Perricone MA, Rees DD, Sacks CR, Smith KA, Kaplan JM, St. George JA. Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells. Hum Gene Ther 2000;11:1997-2008
42. Haddad IY, Sorscher EJ, Garver JI, Hong J, Tzeng E, Matalon S. Modulation of adenovirus-mediated gene transfer by nitric oxide. Am J Respir Cell Mol Biol 1997;16:501-509
43. van Heeckeren A, Ferkol T, Tosi M. Effects of bronchopulmonary inflammation induced by Pseudomonas aeruginosa on adenovirus-mediated gene transfer to airway epithelial cells in mice. Gene Ther 1998;5:345-351
44. Parsons DW, Grubb BR, Johnson LG, Boucher RC. Enhanced in vivo airway gene transfer via transient modification of host barrier properties with a surface-active agent. Hum Gene Ther 1998;9:2661-2672
45. Otake K, Ennist DL, Harrod K, Trapnell BC. Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses. Hum Gene Ther 1998;9:2207-2222
46. Worgall S, Leopold PL, Wolff G, Ferris B, Van Roijen N, Crystal RG. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Hum Gene Ther 1997;8:1675-1684
47. Worgall S, Wolff G, Falck-Pedersen E, Crystal RG. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther 1997;8:37-44
48. Bromberg JS, Debruyne LA, Qin L. Interactions between the immune system and gene therapy vectors: Bidirectional regulation of response and expression. Adv Immunol 1998;69:353-409
49. Look DC, Brody SL. Engineering viral vectors to subvert the airway defense response. Am J Respir Cell Mol Biol 1999;20:1103-1106
50. Morral N, O'Neial W, Zhou H, Langston C, Beaudet A. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors. Hum Gene Ther 1997;8:1275-1286
51. Song W, Kong HL, Traktman P, Crystal RG. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors. Hum Gene Ther 1997;8:1207-1217
52. Yang Y, Jooss KU, Su Q, Ertl HC, Wilson JM. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther 1996;3:137-144
53. Whitsett JA, Dey CR, Stripp BR, et al. Human cystic fibrosis transmembrane conductance regulator directed to respiratory epithelial cells of transgenic mice. Nat Genet 1992;2:13-20
54. Kaplan JM, Smith AE. Transient immunosuppression with deoxyspergualin improves longevity of transgene expression and ability to readminister adenoviral vector to the mouse lung. Hum Gene Ther 1997;8:1095-1104
55. Kaplan J, St. George JA, Pennington SE, et al. Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2. Gene Ther 1996;3:117-127
56. Thorne PS, McCray PB, Howe TS, O'Neill MA. Early-onset inflammatory responses in vivo to adenoviral vectors in the presence or absence of lipopolysaccharaide-induced inflammation. Am J Respir Cell Mol Biol 1999;20:1155-1164
57. Weiss DJ, Bonneau L, Liggitt D. Use of perfluorochemical liquid allows earlier detection and use of less adenovirus vector for gene expression in normal lung and enhances gene expression in acutely injured lung. Molecular Therapy 2001;3:734-745
58. Suzuki M, Suzuki S, Yamamoto N, et al. Immune responses against replication-deficient adenovirus inhibit ovalbumin-specific allergic reactions in mice. Hum Gene Ther 2000;11:827-838
59. Morsy MA, Gu MC, Motzel S, et al. An Adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Appl Biol Sci 1998;95:7866-7871
60. 1-antitrypsin with negligible toxicity. Hum Gene Ther 1998;9:2709-2716
61. Chillón M, Lee JH, Fasbender A, Welsh MJ. Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro. Gene Ther 1998;5:995-1002
62. O'Riordan CR, Lachapell A, Delgado C, et al. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum Gene Ther 1999;10:1349-1358
63. Croyle MA, Chirmule N, Zhang Y, Wilson JM. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J Virol 2001;75:4792-4801
64. White GC, Roberts HR. Gene therapy for hemophilia: a step closer to reality. Mol Ther 2000;1:207-208
65. Green ES, Rendahl KG, Zhou S, et al. Two animal models of retinal degeneration are rescued by recombinant adeno-associated virus-mediated production of FGF-5 and FGF-18. Mol Ther 2001;3:507-515
66. Conrad CK, Allen SS, Afione SA, et al. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther 1996;3:658-668
67. Flotte TR, Solow R, Owens RA, Afione SA, Zeitlin PL, Carter BJ. Gene expression from adeno-associated virus vectors in airway epithelial cells. Am J Respir Cell Mol Biol 1992;7:349-356
68. Flotte TR, Carter BJ. Adeno-associated virus vectors for gene therapy. Gene Ther 1995;2:357-362
69. Halbert CL, Alexander IE, Wolgamot GM, Miller AD. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol 1995;69:1473-1479
70. Duan D, Yue Y, Yan Z, McCray PBJ, Engelhardt JF. Polariry influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. Hum Gene Ther 1998;9:2761-2776
71. Teramoto S, Bartlett JS, McCarty D, Xiao X, Samulski RJ, Boucher RC. Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: comparison with adenovirus vectors. J Virol 1998;72:8904-8912
72. Bals R, Xiao W, Sang N, Weiner DJ, Meegalla RL, Wilson JM. Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry. J Virol 1999;73:6085-6088
73. Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998;72:1438-1445
74. Qing K, Mah C, Hansen J, Zhou S, Dwarki V, Srivastava A. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 1999;5:71-77
75. Summerford C, Bartlett JS, Samulski RJ. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 1999;5:78-82
76. Duan D, Yue Y, Yan Z, Yang J, Engelhardt JF. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J Clin Invest 2000;105:1573-1587
77. Yan Z, Zak R, Luxton GW, Ritchie TC, Bantel-Schaal U, Engelhardt JF. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction effciency of recombinant vectors. J Virol 2002;76:2043-2053
78. Sanlioglu S, Engelhardt JF. Cellular redox state alters recombinate adeno-associated virus transduction through tyrosine phosphatase pathways. Gene Ther 1991;6:1427-1437
79. Sanlioglu S, Benson PK, Yang J, Atkinson EM, Reynolds T, Engelhardt JF. Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by racl and phosphatidylinositol-3 kinase activation. J Virol 2000;74:9184-9196
80. Qing K, Hansen J, Weigel-Kelley KA, Tan M, Zhou S, Srivastava A. Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J Virol 2001;75:8968-8976
81. Halbert CL, Allen JM, Miller AD. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat Biotechnol 2002;20:697-701
82. Ostedgaard LS, Zabner J, Vermeer DW, et al. CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivo. Proc Nad Acad Sci USA 2002;99:3093-3098
83. Aitken ML, Moss RB, Waltz DA, et al. A phase 1 study of aerosolized administration of tgAAVCF to cystic fibrosis patients with mild lung disease. Hum Gene Ther 2001;12:1907-1916
84. Chao H, Liu Y, Rabinowitz J, Li C, Samulski RJ, Walsh CE. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2000;2:619-623
85. Walters R, Yi SM, Keshavjee S, et al. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem 2001;276:20606-20610
86. Kaludov N, Brown KE, Walters RW, Zabner J, Chiorini JA. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol 2001;75:6884-6893
87. Halbert CL, Allen JM, Miller AD. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J Virol 2001;75:6615-6624
88. Walters RW, Yi SM, Keshavjee S, et al. Binding of adeon-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem 2001;276:20610-20616
89. Virella-Lowell I, Poirier A, Chesnut KA, Brantlyn M, Flotte TR. Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients. Gene Ther 2000;7:1783-1789
90. McCray PB, Wang G, Kline JN, et al. Alveolar macrophages inhibit retrovirus-mediated gene transfer to airway epithelia. Hum Gene Ther 1997;8:1087-1093
91. Wang G, Davidson BL, Melchert P, et al. Influence of cell polarity on retrovirus-mediated gene transfer to differentiated human airway epithelial epithelia. J Virol 1998;72:9818-9826
92. Engelhardt JF, Yankaskas JR, Wilson JM. In vivo retroviral gene transfer into human bronchial epithelia of xenografts. J Clin Invest 1992;90:2598-2607
93. Halbert CL, Aitken ML, Miller AD. Retroviral vectors efficiently transduce basal and secretory airway epithelial cells in vitro resulting in persistent gene expression in organotypic culture. Hum Gene Ther 1996;7:1871-1881
94. Pitt BR, Schwarz MA, Pilewski JM, et al. Retrovirus-mediated gene transfer in lungs of living fetal sheep. Gene Ther 1995;2:344-350
95. Wang G, Davidson BL, Melchert P, et al. Influence of cell polarity on retrovirus-mediated gene transfer to differentiated human airway epithelial epithelia. J Virol 1998;72:9818-9826
96. Johnson LG, Mewshaw JP, Ni H, Friedman T, Boucher RC, Olsen JC. Effect of host modification and age on airway epithelial gene transfer mediated by a murine leukemia virus-derived vector. J Virol 1998;72:8861-8872
97. Goldman MJ, Lee PS, Yang JS, Wilson JM. Lentiviral vectors for gene therapy of cystic fibrosis. Hum Gene Ther 1997;8:2261-2268
98. Lever AM. Lentivral vectors: progress and potential. Curr Opin Mol Ther 2000;2:488-496
99. Wang G, Sinn PL, McCray PB Jr. Development of retroviral vectors for gene transfer to airway epithelia. Curr Opin Mol Ther 2000;2:497-506
100. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003;348:255-256
101. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 2003;76:5654-5666
102. Yonemitsu Y, Kitson C, Ferrari S, et al. Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol 2000;18:970-973
103. Slepushkin VA, Staber PD, Wang G, McCray PB Jr, Davidson BL. Infection of human airway epithelia with H1N1, H2N2, and H3N2 Influenza A virus strains. Mol Ther 2001;3:395-402
104. Scheule RK, St. George JA, Bagley RG, et al. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum Gene Ther 1997;8:689-707
105. Tan Y, Liu F, Li Z, Li S, Huang L. Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity. Mol Ther 2001;3:673-682
106. Ruiz FE, Clancy JP, Perricone MA, et al. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum GeneTher 2001;12:751-761
107. Freimark BD, Blezinger HP, Florack VJ, et al. Cationic lipids enhance cytokine and cell influx levels in the lung folloiwng administration of plasmid: cationic lipid complexes. J Immunol 1998;160:4580-4586
108. Li S, Wu SP, Whitmore M, et al. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am J Physiol 1999;276:L796-L804
109. Yew NS, Zhao H, Wu IH, et al. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol Ther 2000;1:255-262
110. Yew NS, Wang KX, Przybylska M, et al. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. Hum Gene Ther 1999;10:223-234
111. Krieg AM. Minding the Cs and Gs. Mol Ther 2000;1:209-210
112. Tsan MF, White JE, Shepard B. Lung-specific direct in vivo gene transfer with recombinant plasmid DNA. Am J Physiol 1995;268:L1052-L1056
113. Tsan MF, White JE, Pastore JN, Hayes VD, Shepard BA, Lee CY. Pulmonary response to plasmid DNA and immunohistochemical localization of transgene expression. Exp Lung Res 1996;22:651-666
114. Kukowska-Latallo JF, Raczka E, Quintana A, Chen C, Rymaszewski M, Baker JR. Intravascular and endobronchial DNA delivery to muring lung tissue using a novel, nonviral vector. Hum Gene Ther 2000;11:1385-1395
115. Raczka E, Kukowska-Latallo JF, Rymaszewski M, Chen C, Baker JR. The effect of synthetic surfactant Exosurf on gene transfer in mouse lung in vivo. Gene Ther 1998;5:1333-1339
116. Yew NS, Wysokenski DM, Wang KX, et al. Optimization of plasmid vectors for high-level expression in lung epithelial cells. Hum Gene Ther 1997;8:575-584
117. Fasbender AJ, Zabner J, Welsh MJ. Optimization of cationic lipid-mediated gene transfer to airway epithelia. Am J Physiol 1995;269:L45-L51
118. Griesenbach U, Chonn A, Cassady R, et al. Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy. Gene Ther 1998;5:181-188
119. Debs R, Pian M, Gaensler K, Clements J, Friend DS, Dobbs L. Prolonged transgene expression in rodent lung cells. Am J Respir Cell Mol Biol 1992;7:406-413
120. Matsui H, Johnson LG, Randell SH, Boucher RC. Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells. J Biol Chem 1997;272:1117-1126
121. Stribling R, Brunette E, Liggitt D, Gaensler K, Debs R. Aerosol gene delivery in vivo. 1995. Proc Natl Acad Sci USA 1992;89:11277-11281
122. Nilsson SK, Dooner MS, Weier HU, et al. Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice. J Exp Med 1999;189:729-734
123. Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Welsh MJ. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995;270:18997-19007
124. Fasbender A, Zabner J, Zeiher BG, Welsh MJ. A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia. Gene Ther 1997;4:1173-1180
125. Tsan MF, Tsan GL, White JE. Surfactant inhibits cationic liposome-mediated gene transfer. Hum Gene Ther 1997;8:817-825
126. Duncan JD, Whitsett JA, Horowitz AD. Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro. Hum Gene Ther 1997;8:431-438
127. Ernst U, Ulrichskotter S, Schmalix WA, et al. Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant. J Gene Med 1999;1:331-340
128. Stern M, Caplen NJ, Browning JE, et al. The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro. Gene Ther 1998;5:91-98
129. Ferrari S, Kitson C, Farley R, et al. Mucus altering agents as adjuncts for nonviral gene transfer to airway-epithelium. Gene Ther 2001;8:1380-1386
130. Harris CE, Agarwal S, Hu P, Wagner E, Curiel DT. Receptor-mediated gene transfer to airway epithelial cells in primary culture. Am J Respir Cell Mol Biol 1993;9:441-447
131. Gao L, Wagner E, Cotten M, et al. Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes. Hum Gene Ther 1993;4:17-24
132. Fajac I, Briand P, Monsigny M, Midoux P. Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells. Hum Gene Ther 1999;10:395-406
133. Kukowska-Latallo JF, Raczka E, Quintana A, Chen C, Rymaszewski M, Baker JR Jr. Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector. Hum Gene Ther 2000;11:1385-1395
134. Schughart K, Bischoff R, Rasmussen UB, et al. Solvoplex: a new type of synthetic vector for intrapulmonary gene delivery. Hum Gene Ther 1999;10:2891-2905
135. Ferkol T, Perales JC, Eckman E, Kaetzel CS, Hanson RW, Davis PB. Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. J Clin Invest 1995;95:493-502
136. Gupta S, Eastman J, Silski C, Ferkol T, Davis PB. Single chain Fv: a ligand in receptor-mediated gene delivery. Gene Ther 2001;8:586-592
137. Ziady AG, Kelley TJ, Milliken E, Ferkol T, Davis PB. Functional evidence of CFTR gene transfer in nasal epithelial of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme comlex receptor. Mol Ther 2002;5:413-419
138. Kollen WJ, Schembri FM, Gerwig GJ, Vliegenthart JF, Glick MC, Scanlin TF. Enhanced efficiency of lactosylated poly-L-lysine-mediated gene transfer into cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 1999;20:1081-1086
139. Gautam A, Densmore CL, Golunski E, Xu B, Waldrep JC. Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes. Mol Ther 2001;3:551-556
140. Gautam A, Densmore CL, Xu B, Waldrep JC. Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery. Mol Ther 2000;2:63-70
141. Gautam A, Densmore CL, Waldrep JC. Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes. Gene Ther 2000;2:318-323
142. Gautam A, Densmore CL, Waldrep JC. Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene Ther 2001;8:254-257
143. Pilewski JM. Gene therapy for airway diseases: continued progress towards identifying and overcoming barriers to efficiency. Am J Respir Cell Mol Biol 2002;27:117-121
144. Weiss DJ. Delivery of gene transfer vectors to lung: obstacles and the role of adjunct techniques for airway administration. Mol Ther 2002;6:148-152
145. Look DC, Brody SL. Engineering viral vectors to subvert the airway defense response. Am J Respir Cell Mol Biol 1999;20:1103-1106
146. Bromberg JS, Debruyne LA, Qin L. Interactions between the immune system and gene therapy vectors: bidirectional regulation of response and expression. Adv Immunol 1998;69:353-409
147. Halbert CL, Standaert TA, Wilson CB, Miller AD. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J Virol 1998;72:9795-9805
148. Zabner J, Ramsey BW, Meeker DP, et al. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest 1996;97:1504-1511
149. Engelhardt JF, Simon RH, Yang Y, et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum Gene Ther 1993;4:759-769
150. Zuckerman JB, Robinson CB, McCoy KS, et al. A Phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum Gene Ther 1999;10:2973-2985
151. Cipolla DC, Gonda I, Shak S, Kovesdi I, Crystal R, Sweeney TD. Coarse spray delivery to a localized region of the pulmonary airways for gene therapy. Hum Gene Ther 2000;11:361-371
152. Harvey BG, Leopold PL, Hackett NR, et al. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J Clin Invest 1999;104:1165-1166
153. Beck SE, Laube BL, Barberena CI, et al. Deposition and expression of aerosolized rAAV vectors in the lungs of rhesus macaques. Mol Ther 2002;6:546-554
154. McDonald RJ, Lukason MJ, Raabe OG, et al. Safety of airway gene transfer with Ad2/CFTR2: aerosol administration in the nonhuman primate. Hum Gene Ther 1997;8:411-422
155. Katkin JP, Gilbert BE, Langston C, French K, Beaudet AL. Aerosol delivery of a β-galactosidase adenoviral vector to the lungs of rodents. Hum Gene Ther 1995;6:985-995
156. Sene C, Bout A, Imler JL, et al. Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates. Hum Gene Ther 1995;6:1587-1593
157. Bellon G, Michel-Calemard L, Thouvenot D, et al. Aerosol administration of a recombinant adenovirus expressing cftr to cystic fibrosis patients: a Phase I clinical trial. Hum Gene Ther 1997;8:15-25
158. Eastman SJ, Tousignant JD, Lukason MJ, Chu Q, Cheng SH, Scheule RK. Aerosolization of cationic lipid:pDNA complexes in vitro optimization of nebulizer parameters for human clinical studies. Hum Gene Ther 1998;9:43-52
159. Brown AR, Chowdhury SI. Propellant-driven aerosols of DNA plasmids for gene expression. J Aerosol Med 1997;10:129-146
160. Stern M, Sorgi F, Hughes C, et al. The effects of jet nebulisation on cationic liposome-mediated gene transfer in vitro. Gene Ther 1998;5:583-593
161. Crook K, McLachlan G, Stevenson BJ, Porteous DJ. Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolization. Gene Ther 1996;3:834-839
162. Muir DFC. Particle Deposition: The Lung: Scientific Foundations, 1839-1843. New York: Raven Press Ltd; 1991
163. Walters RW, van't Hof W, Yi SM, et al. Apical localization of the coxsackie-adenovirus receptor by glycosyl-phosphatidylinositol modification is sufficient for adenovirus-mediated gene transfer through the apical surface of human airway epithelia. J Virol 2001;75:7703-7711
164. Zhang HG, Zhou T, Yang P, Edwards CKI, Curiel DT, Mountz JD. Inhibition of tumor necrosis factor α decreases inflammation and prolongs adenovirus gene expression in lung and liver. Hum Gene Ther 1998;9:1875-1884
165. Bastian A, Bewig B. Inhibition of adenovirus-mediated gene transfer by bronchoalveolar lavage fluid. Gene Ther 1999;6:637-642
166. Bastian A, Schafer H. Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro. Regul Pept 2001;101:157-161
167. Jobe AH, Ueda T, Whitsett JA, Trapnell BC, Ikegami M. Surfactant enhances adenovirus-mediated gene expression in rabbit lungs. Gene Ther 1996;3:775-779
168. Katkin JP, Husser RC, Langston C, Welty SE. Exogenous surfactant enhances the delivery of recombinant adenoviral vectors to the lung. Hum Gene Ther 1997;8:171-176
169. Arcasoy SM, Latoche J, Gondor M, et al. MUC1 and other sialoglycoconjugates inhibit adenovirus-mediated gene transfer. Am J Respir Cell Mol Biol 1997;17:422-435
170. Worgall S, Leopold PL, Wolff G, Ferris B, Van Roijen N, Crystal RG. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Hum Gene Ther 1997;8:1675-1684
171. Yang Y, Greenough K, Wilson JM. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther 1996;3:412-420
172. Halbert CL, Standaert TA, Aitken ML, Alexander IE, Russell DW, Miller AD. Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and read-ministration. J Virol 1997;71:5932-5941
173. Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med 1995;1:890-893
174. Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995;69:2004-2015
175. Lei D, Lehmann M, Shellito JE, et al. Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats. Hum Gene Ther 1996;7:2273-2279
176. Scaria A, St. George JA, Gregory RJ, et al. Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway. Gene Ther 1997;4:611-617
177. Shean MK, Baskin G, Sullivan D, et al. Immunomodulation and adenoviral-mediated gene transfer to the lungs of non-human primates. Hum Gene Ther 2000;11:1047-1055
178. Rahman A, Tsai V, Goudreau A, et al. Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapy. Mol Ther 2001;3:768-778
179. a. Scott ES, Wiseman JW, Evans MJ, Colledge WH. Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex. J Gene Med 2001;3:125-134
180. Drapkin PT, O'Riordan CR, Yi SM, et al. Targeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelia. J Clin Invest 2000;105:589-596
181. Kreda SM, Pickles RJ, Lazarowski ER, Boucher RC. G-protein-coupled receptors as targets for gene transfer vectors using natural small-molecule ligands. Nat Biotechnol 2000;18:635-640
182. Romanczuk H, Galer CE, Zabner J, Barsomian G, Wadsworth SC, O'Riordan CR. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice. Hum Gene Ther 1999;10:2615-2626
183. Sakhuja K, Reddy PS, Ganesh S, et al. Optimization of the generation and propagation of gutless adenoviral vectors. Hum Gene Ther 2003;14:243-254
184. Lee JH, Zabner J, Welsh MJ. Delivery of an adenovirus vector in a calcium phosphate coprecipitate enhances the therapeutic index of gene transfer to airway epithilia. Hum Gene Ther 1999;10:603-613
185. Fasbender A, Lee JH, Walters RW, Moninger TO, Zabner J, Welsh MJ. Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J Clin Invest 1998;102:184-193
186. Walters RW, Duan D, Engelhardt J, Welsh MJ. Incorporation of adeno-associated virus in a calcium phosphate coprecipitate improves gene transfer to airway epithelia in vitro and in vivo. J Virol 2000;74:535-540
187. Arcasoy SM, Latoche JD, Gondor M, Pitt BR, Pilewski JM. Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro. Gene Ther 1997;4:32-38
188. Coyne CB, Kelly MM, Boucher RC, Johnson LG. Enhanced epithelial gene transfer by modulation of tight junctions with sodium caprate. Am J Respir Cell Mol Biol 2000;23:602-609
189. Gregory LG, Harbottle RP, Lawrence L, Knapton HJ, Themis M. Coutelle C. Enhancement of adenovirus-mediated gene transfer to the airways by DEAE dextran and sodium caprate in vivo. Mol Ther 2003;7:19-26
190. Zabner J, Zeiher BG, Friedman E, Welsh MJ. Adenovirus-mediated gene transfer to ciliated airway epithelia requires pronlonged incubation time. J Virol 1996;70:6994-7003
191. Jiang C, Akita GY, Colledge WH, et al. Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF mice. Hum Gene Ther 1997;8:671-680
192. Seiler MP, Luner P, Moninger TO, Karp PH, Keshavjee S, Zabner J. Thixotropic solutions enhance viral-mediated gene transfer to airway epithelia. Am J. Repir Cell Mol Biol 2002;27:133-140
193. Greenough A. Expanded use of surfactant replacement therapy. Eur J Pediatr 2001;159:635-640
194. Factor P, Saldias F, Ridge K, et al. Augmentation of lung liquid clearance via adenovirus-mediated transfer of a Na, K-ATPase beta1 subunity gene. J Clin Invest 1998;102:1421-1430
195. Factor P, Mendez M, Mutlu GM, Dumasius V. Acute hyperoxic lung injury does not impede adenoviral-mediated alveolar gene transfer. Am J Respir Crit Care Med 2002;165:521-526
196. Shaffer TH, Wolfson MR, Clark LC. Liquid ventilation. Pediatr Pulmonol 1992;14:102-109
197. Leach CL, Greenspan JS, Rubenstein SD, et al. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N Engl J Med 1996;335:761-767
198. Hirschl RB, Conrad S, Kaiser R, et al. Partial liquid ventilation in adult patients with ARDS: a multicenter phase I-II trial. Adult PLV Study Group. Ann Surg 1998;228:692-700
199. Papo MC, Paczan PR, Fuhrman BP, et al. Perfluorocarbon-associated gas exchange improves oxygenation, lung mechanics, and survival in a model of adult respiratory distress syndrome. Crit Care Med 1996;24:466-474
200. Colton DM, Till GO, Johnson KJ, Dean SB, Bartlett RH, Hirschl RB. Neutrophil accumulation is reduced during partial liquid ventilation. Crit Care Med 1998;26:1716-1724
201. Croce MA, Fabian TC, Patton JH, Melton SM, Moore M, Trenthem LL. Partial liquid ventilation decreases the inflammatory response in the alveolar environment of trauma patients. J Trauma 1998;45:273-282
202. Lisby DA, Ballard PL, Fox WW, Wolfson MR, Shaffer TH, Gonzales LW. Enhanced Distribution of Adenovirus-Mediated Gene Transfer to Lung Parenchyma by Perfluorochemical Liquid. Hum.Gene.Ther 1997;8:919-928
203. Weiss DJ, Strandjord TP, Jackson JC, Clark JG, Liggitt D. Perfluorochemical liquid-enhanced adenoviral vector distribution and expression in lungs of spontaneously breathing rodents. Exp Lung Res 1999;25:317-333
204. Weiss DJ, Bonneau L, Allen JM, Miller AD, Halbert CL. Perfluorochemical liquid enhances adeno-associated virus-mediated transgene expression in lung. Mol Ther 2000;2:624-630
205. Weiss DJ, Baskin GB, Shean MK, Blanchard JL, Kolls JK. Use of perflubron to enhance lung gene expression: safety and initial efficacy studies in non-human primates. Mol Ther 2002;5:8-15
206. Weiss DJ, Niven RW, Strandjord TP, Liggitt D, Clark JG. Perfluorochemical liquid-enhanced liposomal-mediated gene transfer to lungs of spontaneously breathing rats. Pediatr Pulmonol 1998;17:269
207. Lerondel S, Le Pape A, Sene C, et al. Radioisotopic imaging allows optimization of adenovirus lung deposition for cystic fibrosis gene therapy. Hum Gene Ther 2001;12:1-11
208. Weiss DJ, Strandjord TP, Liggitt D, Clark JG. Perflubron enhances adenoviral-mediated gene expression in lungs of transgenic mice with chronic alveolar filling. Hum Gene Ther 1999;10:2287-2293
209. Bonneau L, Shaffer TH, Lukason TM, St.George J, Wolfson MR. Ingestion in vivo by alveolar macrophages of perflorochemical (PFC) liquid correlates with altered proinflammatory cytokine release. Am J Respir Crit Care Med 2000;161:A902
210. Weiss DJ, Beckett T, Bonneau L, et al. Transient increase in lung epithelial tight junction permeability: an additional mechanism for enhancement of lung transgene expression by perfluorochemical liquids. Molecular Therapy 2003;8:927-935
211. Weiss DJ, Bonneau L, Liggitt D. Inhalation of nebulized perflubron enhhances adenovirus mediated gene expression in lung epithelium. Mol Ther 2003;5:S68
212. McLean JW, Fox EA, Baluk P, et al. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Physiol (Heart Circ Physiol) 1997;273:H387-H404
213. Huard J, Lochmuller H, Acsadi G, Jani A, Bassie B, Karpati G. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 1995;2:107-115
214. Rodman DM, San H, Simari R, et al. In vivo gene delivery to the pulmonary circulation in rats: transgene distribution and vascular inflammatory response. Am J Respir Cell Mol Biol 1997;16:640-649
215. Zhang Y, Chirmule N, Gao GP, et al. Acute cytokine response to systemic adenovial vectors in mice is mediated by dendritic cells and macrophages. Mol Ther 2001;3:697-707
216. Albelda SM, Wiewrodt R, Zuckerman JB. Gene therapy for lung disease: hype or hope? Ann Intern Med 2000;132:649-660
217. Joseph PM, O'Sullivan BP, Lapey A, et al. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications. Hum Gene Ther 2001;12:1369-1382
218. Wagner JA, Nepomuceno IB, Messner AH, et al. A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF used maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum Gene Ther 2002;13:1349-1359
219. Wagner JA, Messner AH, Moran ML, et al. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAC-CFTR) in the cystic fibrosis maxillary sinus. Larynogoscope 1999;109:266-274
220. Harvey BG, Maroni J, O'Donoghue KA, et al. Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum Gene Ther 2002;13:15-63
221. Hyde SC, Southern KW, Gileadi U, et al. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther 2000;7:1156-1165
222. Porteous DJ, Dorin JR, McLachlan G, et al. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther 1997;4:210-218
223. g. Hay JG, McElvaney NG, Herena J, Crystal RG. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector. Hum Gene Ther 1995;6:1487-1496
224. Caplen NJ, Alton EW, Middelton PG, et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med 1995;1:39-46
225. McElvaney NG, Crystal RG. IL-6 release and airway administration of human CFR cDNA adenovirus vector. Nat Med 1995;1:182-184
226. Zabner J, Couture LA, Gregory RJ, Graham SM, Smith AE, Welsh MJ. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993;75:207-216
227. Knowles MR, Hohneker KW, Zhou Z, et al. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 1995;333:823-831
228. McElvaney NG, Crystal RG. IL-6 release and airway administration of human CFR cDNA adenovirus vector. Nat Med 1995;1:182-184
229. Balter M. Gene therapy on trial. Science 2000;288:951-957
230. Flotte TR, Afione SA, Conrad C, et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 1993;90:10613-10617
231. Conrad CK, Allen SS, Afione SA, et al. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther 1996;3:658-668
232. Wagner JA, Reynolds T, Moran ML, et al. Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus. Lancet 1998;351:1702-1703
233. Moss RB, Aitken M, Clancy J, et al. A multi-center, double-blind, placebo controlled, phase II study of aerosolized TGAAVCFTR in cystic fibrosis patients with mild lung disease. Pediatr Pulmonol 2002;S24:A210
234. Alton EW, Stern M, Farley R, et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 1999;353:947-954
235. Noone PG, Hohneker KW, Zhou Z, et al. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol Ther 2000;1:105-114
236. Zabner J, Cheng SH, Meeker D, et al. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J Clin Invest 1997;100:1529-1537
237. Alton EW, Stern M, Farley R, et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 1999;353:947-954
238. Reynolds SD, Giangreco A, Power JH, Stripp BR. Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol 2000;156:269-278
239. Reynolds SD, Hong KU, Giangreco A, et al. Conditional clara cell ablation reveals a self-renewing progenitor function of pulmonary neuroendocrine cells. Am J Physiol (Lung Cell Molec Physiol) 2000;278:L1256-1263
240. Hong KU, Reynolds SD, Giangreco A, Hurley CM, Stripp BR. Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol 2001;24:671-681
241. Giangreco A, Reynolds SD, Stripp BR. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 2002;161:173-182
242. Engelhardt JF, Schlossberg H, Yankaskas JR, Dudus L. Progenitor cells of the adult human airway involved in submucosal gland development. Development 1995;121:2031-2046
243. Zepeda ML, Chinoy MR, Wilson JM. Characterization of stem cells in human airway capable of reconstituting a fully differentiated bronchial epithelium. Somat Cell Mol Genet 1995;21:61-73
244. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49
245. Hirschi KK, Goodell MA. Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Gene Ther 2002;9:648-652
246. Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000;290:1775-1779
247. Kotton DN, Ma BY, Cardoso WV, et al. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 2001;128:5181-5188
248. Wang X, Montini E, Al-Dhalimy M, Lagasse E, Finegold M, Grompe M. Kinetics of liver repopulation after bone marrow transplantation. Am J Pathol 2002;161:565-574
249. Wagers AJ, Christensen JL, Weissman IL. Cell fate determination from stem cells. Gene Ther 2002;9:606-612
250. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105:369-377
251. Theise ND, Henegariu O, Grove J, et al. Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow. Exp Hematol 2002;30:1333-1338
252. Grove JE, Lutzko C, Priller J, et al. Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium. Am J Respir Cell Mol Biol 2002;27:645-651
253. Bruscia E, Sangiuolo F, Sinibaldi P, Goncz KK, Novelli G, Gruenert DC. CFTR locus by SFHR-mediated targeting. Gene Ther 2002;9:683-685
254. Liu X, Jiang Q, Mansfield SG, et al. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by sliceosome-mediated RNA trans-splicing. Nat Biotechnol 2002;20:47-52